Nazartinib, also known as EGF816, is an orally available, irreversible, third-generation, mutant-selective epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity.
For research use only. We do not sell to patients.
Chemical Information
Name Nazartinib (EGF816)
Iupac Chemical Name (R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide
Synonyms EGF816;EGF-816;EGF 816;Nazartinib
Molecular Formula C26H31ClN6O2
Molecular Weight 495.02
Smile ClC1=CC=CC2=C1N(C(=N2)NC(C2=CC(=NC=C2)C)=O)[C@H]2CN(CCCC2)C(\C=C\CN(C)C)=O
InChiKey IOMMMLWIABWRKL-WUTDNEBXSA-N
InChi InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1
CAS Number 1508250-71-2
Related CAS
Ordering Information
Packaging Price Availability Purity Shipping Time
Bulk Enquiry Enquiry Enquiry
Formulation off-white solid
Purity 98.0%
Storage -20 ºC for 3 years
Solubility Soluble in DMSO
Handling
Shipping Condition Shipped under ambient temperature
HS Code
Targets
Mechanism
Cell study
Animal study
Clinical study